For the moment, let's ignore that case by simply calling the improved drug a new drug.
> However, sometimes the added value is minuscule. In that case insurance companies should just say "we're not paying for it since the added cost is not worth it".
I'm still lost.
1. Doctor writes prescription for "B", which is really "A" with an insignificant change and a price bump.
2. Patient goes to pharmacy and looks at their copay for "B." Whoa! they say-- that is surprisingly high.
Wouldn't the pharmacist then have the responsibility to jump in with their expertise at this point? Say: "B" is just a slightly altered "A" to get you to pay more, so call your doctor and ask them if you can take "A."